{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:07:46Z","timestamp":1759410466865},"reference-count":47,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.2217\/fmb.10.137","type":"journal-article","created":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T16:17:35Z","timestamp":1291652255000},"page":"1629-1640","source":"Crossref","is-referenced-by-count":4,"title":["Novel Quadrivalent Meningococcal A, C, W-135 and Y Glycoconjugate Vaccine for the Broader Protection of Adolescents and Adults"],"prefix":"10.1080","volume":"5","author":[{"given":"David","family":"Pace","sequence":"first","affiliation":[{"name":"Department of Paediatrics,Mater Dei Hospital,Tal-Qroqq,\rMsida,\rMSD 2090,\rMalta."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,12,6]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2006.00060.x"},{"key":"e_1_3_2_4_1","first-page":"1","article-title":"National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC): Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"54","author":"Bilukha OO","year":"2005","unstructured":"Bilukha OO , RosensteinN; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC): Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm. Rep.54(RR-7) , 1\u201321 (2005).","journal-title":"MMWR Recomm. Rep."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.6.694"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/340414"},{"issue":"37","key":"e_1_3_2_7_1","first-page":"1042","article-title":"Centers for Disease Control and Prevention (CDC): Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.","volume":"58","year":"2009","unstructured":"Centers for Disease Control and Prevention (CDC): Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb. Mortal Wkly Rep. 58(37) , 1042\u20131043 (2009).","journal-title":"MMWR Morb. Mortal Wkly Rep."},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199611000-00009"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.032"},{"issue":"2","key":"e_1_3_2_10_1","first-page":"325","article-title":"Epidemic group C meningococcal meningitis in Upper Volta, 1979.","volume":"61","author":"Broome CV","year":"1983","unstructured":"Broome CV , RughMA, YadaAAet al. : Epidemic group C meningococcal meningitis in Upper Volta, 1979.Bull. World. Health Organ.61(2) , 325\u2013330 (1983).","journal-title":"Bull. World. Health Organ."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2009.80.619"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90224-7"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3180cc2c25"},{"key":"e_1_3_2_14_1","first-page":"17","article-title":"The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens.","volume":"319","author":"Mond JJ","year":"2008","unstructured":"Mond JJ , Kokai-KunJF: The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens.Curr. Top. Microbiol. Immunol.319 , 17\u201340 (2008).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/527401"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.067"},{"issue":"9","key":"e_1_3_2_17_1","first-page":"273","article-title":"Centers for Disease Control and Prevention (CDC): Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use \u2013 Advisory Committee on Immunization Practices (ACIP) 2010.","volume":"59","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC): Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use \u2013 Advisory Committee on Immunization Practices (ACIP) 2010. MMWR 59(9) , 273 (2010).","journal-title":"MMWR"},{"key":"e_1_3_2_18_1","first-page":"1","article-title":"National Advisory Committee on Immunization (NACI): Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).","volume":"33","year":"2007","unstructured":"National Advisory Committee on Immunization (NACI): Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS). Can. Commun. Dis. Rep. 33(ACS-3) , 1\u201323 (2007).","journal-title":"Can. Commun. Dis. Rep."},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.08.075"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.064"},{"key":"e_1_3_2_21_1","unstructured":"Vesikari T KarvonenA KorhonenT PoolmanJ BoutriauD: Immunogenicity of one dose of an investigational meningococcal tetravalent tetanus\u2013toxoid conjugate (ACWY-TT) vaccine in 2\u201310 year olds. Presented at: Proceedings of the 27th Annual Meeting of the European Society for Paediatric Infectious Diseases-ESPID . Brussels Belgium 9\u201313 June 2009."},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.01.022"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6215(96)00253-4"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31818a0237"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1086\/599117"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00068-09"},{"key":"e_1_3_2_30_1","unstructured":"Gill CJ AnemonaA CiavarroG DeToraL BedellL DullP: Persistence of bactericidal activity in adolescents 12 and 21 months following receipt of meningococcal vaccines against serogroup A C W-135 and Y. Presented at: Proceedings of the 28th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) . Nice France Poster Abstract 4\u20138 May 2010."},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00436-09"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.045"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00207-09"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2010.03.017"},{"key":"e_1_3_2_35_1","volume-title":"Notice of Decision for Menveo. Health Canada, ON, Canada,","year":"2010","unstructured":"Health Canada. Drugs and Health products. Notice of Decision for Menveo. Health Canada, ON, Canada, 23 June 2010."},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-175"},{"key":"e_1_3_2_37_1","first-page":"1","article-title":"National Advisory Committee on Immunization (NACI). An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).","volume":"35","year":"2009","unstructured":"National Advisory Committee on Immunization (NACI). An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS). Can. Commun. Dis Rep. 35(ACS-3) , 1\u201340 (2009).","journal-title":"Can. Commun. Dis Rep."},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.104"},{"issue":"2","key":"e_1_3_2_39_1","first-page":"173","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.","volume":"299","author":"Snape MD","year":"2009","unstructured":"Snape MD , PerrettKP, FordKJet al. : Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.JAMA299(2) , 173\u2013184 (2009).","journal-title":"JAMA"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31818e037d"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39563.545255.AE"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.10.907"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi160"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.02.010"},{"key":"e_1_3_3_2_1","unstructured":"European Union Invasive Bacterial Infections Surveillance (EU-IBIS) Network. Invasive Neisseria meningitidis in Europe 2006. Health Protection Agency London 2006 www.euibis.org"},{"key":"e_1_3_3_3_1","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs): Surveillance Reports Neisseria meningitidis ; 1999\u20132008 www.cdc.gov\/abcs\/reports-findings\/surv-reports.html (Accessed 19April2010)"},{"key":"e_1_3_3_4_1","unstructured":"Novartis Vaccines and Diagnostics: Novartis Receives Approval in the European Union for Menveo\u00ae First Quadrivalent Conjugate Vaccine in the EU to Help Prevent Meningococcal Disease .\n Novartis Vaccines and Diagnostics Press release 18 March 2010 www.novartis.com\/newsroom\/media-releases\/en\/2010\/1395085.shtml (Accessed 24 October 2010)"},{"key":"e_1_3_3_5_1","unstructured":"Summary of product characteristics; Menveo Novartis Vaccines www.medicines.org.uk\/emc (Accessed 9August2010)"},{"key":"e_1_3_3_6_1","unstructured":"CDC vaccine price list www.cdc.gov\/vaccines\/programs\/vfc\/cdc-vac-price-list.htm (Accessed 8August2010)"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb.10.137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:40:18Z","timestamp":1719124818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb.10.137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.2217\/fmb.10.137"],"URL":"https:\/\/doi.org\/10.2217\/fmb.10.137","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}